featured
Intravitreal Anti-VEGF Injections vs Intravitreal Dexamethasone Injections for Central Retinal Vein Occlusion
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The British Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicentre Study of 4626 Patients Assesses the Effectiveness, Safety and Burden of Two Categories of Treatments for Central Retinal Vein Occlusion: Intravitreal Anti-Vascular Endothelial Growth Factor Injections and Intravitreal Ozurdex Injections
Br J Ophthalmol 2020 Sep 22;[EPub Ahead of Print], R Gale, C Gill, M Pikoula, AY Lee, RLW Hanson, S Denaxas, C Egan, A Tufail, P TaylorFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.